Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Peptide Immunization Indicates that CD8+ T Cells are the Dominant Effector Cells in Trinitrophenyl-Specific Contact Hypersensitivity  Stefan Martin, Michael.
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 26, Issue 3, Pages (March 2007)
Volume 13, Issue 5, Pages (November 2000)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Volume 9, Issue 4, Pages (October 1998)
Volume 31, Issue 2, Pages (August 2009)
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
Volume 11, Issue 4, Pages (October 1999)
Volume 26, Issue 2, Pages (February 2007)
Volume 9, Issue 4, Pages (October 1998)
Volume 11, Issue 6, Pages (December 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 4, Issue 3, Pages (March 1996)
Volume 13, Issue 3, Pages (September 2000)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Impaired Th2 Subset Development in the Absence of CD4
CD22 is a negative regulator of B-cell receptor signalling
Volume 8, Issue 6, Pages (June 1998)
Volume 24, Issue 3, Pages (March 2006)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor–mediated p38α activation and impairs interferon-γ production by Ludmila Jirmanova,
Volume 13, Issue 4, Pages (October 2000)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 9, Issue 5, Pages (November 1998)
Volume 8, Issue 1, Pages (January 1998)
Volume 14, Issue 5, Pages (May 2001)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Altered Antigen Presentation in Mice Lacking H2-O
Volume 33, Issue 4, Pages (October 2010)
Volume 15, Issue 5, Pages (November 2001)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Impaired Development of Th2 Cells in IL-13-Deficient Mice
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Altered Antigen Presentation in Mice Lacking H2-O
Volume 16, Issue 6, Pages (June 2002)
Volume 84, Issue 4, Pages (February 1996)
Immune Response in Stat2 Knockout Mice
Volume 35, Issue 2, Pages (August 2011)
Volume 15, Issue 2, Pages (August 2001)
Volume 16, Issue 3, Pages (March 2002)
Volume 8, Issue 1, Pages (January 1998)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Volume 10, Issue 4, Pages (April 1999)
Volume 16, Issue 4, Pages (April 2002)
TRAF1 Is a Negative Regulator of TNF Signaling
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Volume 27, Issue 4, Pages (October 2007)
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 9, Issue 3, Pages (September 1998)
Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 
Volume 14, Issue 1, Pages (January 2001)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 15, Issue 4, Pages (October 2001)
Volume 24, Issue 1, Pages (January 2006)
Volume 10, Issue 2, Pages (February 1999)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Interleukin-17 is Produced by Both Th1 and Th2 Lymphocytes, and Modulates Interferon-γ- and Interleukin-4-Induced Activation of Human Keratinocytes  Cristina.
Volume 4, Issue 5, Pages (May 1996)
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Stat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells  Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby  Immunity  Volume 4, Issue 3, Pages 313-319 (March 1996) DOI: 10.1016/S1074-7613(00)80439-2

Figure 1 Generation and Analysis of Stat6−/− Mice (A) Schematic of the targeting construct used to disrupt the Stat6 gene. The two exons of the Stat6 gene that were replaced with the neomycin resistance gene are indicated as closed bars and the positions of other exons are not shown. 5′ and 3′ probes used to verify correctly targeted clones are indicated under the mutant allele. Restriction enzymes are the following: B, BamHI; Bg, BglI; H2, HindII. (B) Southern (DNA) analysis of tail DNA from an intercross litter digested with BamHI and hybridized with the 5′ probe indicated in (A). The approximate size of the wild-type band is 3.5 kb and the mutant band is 1.9 kb. (C) Immunoblot analysis of total cell extracts from spleen and thymus of mice wild-type, heterozygous, or homozygous-deficient for the Stat6 gene. As a control, filters were also probed with an antibody specific for Stat1. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 1 Generation and Analysis of Stat6−/− Mice (A) Schematic of the targeting construct used to disrupt the Stat6 gene. The two exons of the Stat6 gene that were replaced with the neomycin resistance gene are indicated as closed bars and the positions of other exons are not shown. 5′ and 3′ probes used to verify correctly targeted clones are indicated under the mutant allele. Restriction enzymes are the following: B, BamHI; Bg, BglI; H2, HindII. (B) Southern (DNA) analysis of tail DNA from an intercross litter digested with BamHI and hybridized with the 5′ probe indicated in (A). The approximate size of the wild-type band is 3.5 kb and the mutant band is 1.9 kb. (C) Immunoblot analysis of total cell extracts from spleen and thymus of mice wild-type, heterozygous, or homozygous-deficient for the Stat6 gene. As a control, filters were also probed with an antibody specific for Stat1. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 1 Generation and Analysis of Stat6−/− Mice (A) Schematic of the targeting construct used to disrupt the Stat6 gene. The two exons of the Stat6 gene that were replaced with the neomycin resistance gene are indicated as closed bars and the positions of other exons are not shown. 5′ and 3′ probes used to verify correctly targeted clones are indicated under the mutant allele. Restriction enzymes are the following: B, BamHI; Bg, BglI; H2, HindII. (B) Southern (DNA) analysis of tail DNA from an intercross litter digested with BamHI and hybridized with the 5′ probe indicated in (A). The approximate size of the wild-type band is 3.5 kb and the mutant band is 1.9 kb. (C) Immunoblot analysis of total cell extracts from spleen and thymus of mice wild-type, heterozygous, or homozygous-deficient for the Stat6 gene. As a control, filters were also probed with an antibody specific for Stat1. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 2 Flow Cytometric Analysis of Lymphocytes From Control and Stat6−/− Mice Lymph node cells from heterozygous or Stat6 homozygous-deficient mice were incubated for 18 hr in either medium alone (fine lines) or medium plus 1,000 U/ml IL-4 (bold lines). Cells were stained with either a cocktail of antibodies specific for I-Ad, I-Ed, and I-Ab and analyzed for MHC class II expression on B220+ cells (left) or with an antibody specific for the α chain of the IL-4R (right). Log fluorescence intensity is shown on the X axis and cell number on the Y axis. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 3 Proliferation of Lymphocytes from Control or Stat6−/− in Response to IL-4 or IL-2 Lymph node cells were stimulated with increasing doses of either (A) IL-4 or (B) IL-2 for 48 hr and pulsed for the last 18 hr of culture with [3H]thymidine. Symbols indicate the mean of triplicate wells ± SEM. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 4 Analysis of Immunoglobulin Isotype Production by Control and Stat6−/− B Lymphocytes Control (open bars) and Stat6−/− (stippled bars) mice were immunized with 200 μg anti-IgD and bled 9 days after injection. Immunoglobulin isotypes in pre- and post-bleeds were quantitated by ELISA. Concentrations of antibody are shown in micrograms/milliliter. Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 5 Cytokine Analysis of In Vitro Differentiated T Lymphocytes from Control and Stat6−/− Mice Spleen cells from control and Stat6−/− mice were activated with anti-CD3 and cultured under conditions that skew their development towards either (A) Th1 cells (IL-12 plus anti-IL-4), (B) Th2 cells (IL-4 plus anti-IFNγ), or (C) Th2 cells (IL-13 + anti-IFNγ). After 7 days in culture, cells were restimulated with anti-CD3 and supernatants were collected 24 hr later and analyzed for the presence of cytokines by ELISA. The amount of IL-4 and IL-5 produced by Th2-differentiated cells from Stat6−/− mice was at or below the level of detection (2 ng/ml, IL-4; 50 U/ml, IL-5). Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 5 Cytokine Analysis of In Vitro Differentiated T Lymphocytes from Control and Stat6−/− Mice Spleen cells from control and Stat6−/− mice were activated with anti-CD3 and cultured under conditions that skew their development towards either (A) Th1 cells (IL-12 plus anti-IL-4), (B) Th2 cells (IL-4 plus anti-IFNγ), or (C) Th2 cells (IL-13 + anti-IFNγ). After 7 days in culture, cells were restimulated with anti-CD3 and supernatants were collected 24 hr later and analyzed for the presence of cytokines by ELISA. The amount of IL-4 and IL-5 produced by Th2-differentiated cells from Stat6−/− mice was at or below the level of detection (2 ng/ml, IL-4; 50 U/ml, IL-5). Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)

Figure 5 Cytokine Analysis of In Vitro Differentiated T Lymphocytes from Control and Stat6−/− Mice Spleen cells from control and Stat6−/− mice were activated with anti-CD3 and cultured under conditions that skew their development towards either (A) Th1 cells (IL-12 plus anti-IL-4), (B) Th2 cells (IL-4 plus anti-IFNγ), or (C) Th2 cells (IL-13 + anti-IFNγ). After 7 days in culture, cells were restimulated with anti-CD3 and supernatants were collected 24 hr later and analyzed for the presence of cytokines by ELISA. The amount of IL-4 and IL-5 produced by Th2-differentiated cells from Stat6−/− mice was at or below the level of detection (2 ng/ml, IL-4; 50 U/ml, IL-5). Immunity 1996 4, 313-319DOI: (10.1016/S1074-7613(00)80439-2)